As of May 27, 2025, Orexo AB's estimated intrinsic value ranges from $0.00 to $0.00 per share, depending on the valuation methodology applied.
Valuation Method | Fair Value (USD) | Implied Upside/Downside |
---|
Is Orexo AB (ORX.ST) undervalued or overvalued?
With the current market price at $15.62, the stock appears to be significantly overvalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate Orexo AB's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
WACC Component | Low | High |
---|---|---|
Long-term bond rate | 2.5% | 3.0% |
Equity market risk premium | 5.1% | 6.1% |
Adjusted beta | 0.4 | 0.43 |
Cost of equity | 5.1% | 6.6% |
Cost of debt | 7.0% | 7.9% |
Tax rate | 5.6% | 7.3% |
Debt/Equity ratio | 0.89 | 0.89 |
After-tax WACC | 5.8% | 7.0% |
Metric | Value |
---|---|
Market Capitalization | $542M |
Enterprise Value | $895M |
Trailing P/E | 0.00 |
Forward P/E | 0.00 |
Trailing EV/EBITDA | 7.75 |
Current Dividend Yield | 62.96% |
Dividend Growth Rate (5Y) | 0.00% |
Debt-to-Equity Ratio | 0.89 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
Valuation Method | Weight | Weighted Value |
---|---|---|
Weighted Average | 100% | $0.00 |
Based on our comprehensive valuation analysis, Orexo AB's weighted average intrinsic value is $0.00, which is approximately 100.0% below the current market price of $15.62.
Key investment considerations:
Given these factors, we believe Orexo AB is currently significantly overvalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.